Here are a few newsworthy items in the world of cancer research:

• A recent post on the NIH Director’s Blog, provided details of Dr. Roger Tsien’s (Nobel Prize winner for Chemistry in 2008) innovative imaging method to infuse electron microscopy with color. For more, see article in Cell Chemical Biology.
• Scientists at Dana Farber have found a potential explanation as to why younger cancer patients are more vulnerable to treatment toxicities. They report in Cancer Cell that tissues in developing organs are more susceptible to cell death when exposed to chemotherapy and radiation.
• Bioinformatics sheds light on new combination therapies to fight breast cancer. The analysis was conducted by researchers at the Institute for Research of Biomedicine in Barcelona.  An exhaustive assessment of the pairing of 64 therapies allowed scientists to identify 10 new combinations previously untested that may have potential for breast cancer treatment.  More in Cancer Research.
• Addressing the matter of diversity and inclusion in cancer clinical trials was the topic of a recent New York Times article by Denise Grady. While more innovative treatments like immunotherapy are taking off, most patients benefiting from these therapies are mainly white. A major obstacle facing people of color include less awareness of medical studies.  Researchers are very aware of the issue and are trying to rectify it.